Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Intra-Cellular Therapies Inc. (NASDAQ: ITCI).

Full DD Report for ITCI

You must become a subscriber to view this report.


Recent News from (NASDAQ: ITCI)

New Research: Key Drivers of Growth for Intra-Cellular Therapies, The, Bassett Furniture Industries, NVE, Equity Bancshares, and Cable One - Factors of Influence, Major Initiatives and Sustained Production
NEW YORK, Sept. 05, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Intra-Cellular Therapies Inc. (NASDAQ:ITCI), The Bancorp, Inc. (NASDAQ:T...
Source: GlobeNewswire
Date: September, 05 2018 07:55
Intra-Cellular Therapies Appoints Dr. Suresh Durgam as Senior Vice President, Late Stage Clinical Development and Medical Affairs
NEW YORK, Aug. 20, 2018 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, announced the expansion of the senior leadership team with the appointment of Sur...
Source: GlobeNewswire
Date: August, 20 2018 08:00
Detailed Research: Economic Perspectives on Neos Therapeutics, Federated National Holding, FutureFuel, Golden Entertainment, Intra-Cellular Therapies, and HTG Molecular Diagnostics - What Drives Growth in Today's Competitive Landscape
NEW YORK, Aug. 15, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Neos Therapeutics, Inc. (NASDAQ:NEOS), Federated National Holding Company...
Source: GlobeNewswire
Date: August, 15 2018 07:35
Intrinsic Value Of Acadia: Deep Dive And Financial Analysis
The stock price of ACADIA Pharmaceutical Inc. ( ACAD ) dropped >60% in the last 9 months from ~40 to 14-ish. A few reasons may explain this dramatic fall including 1) lack of catalyst in terms of clinical readout and market/regulatory events; 2) concerns on sustained revenue growth; 3) nega...
Source: SeekingAlpha
Date: August, 07 2018 09:15
Intra-Cellular Therapies' (ITCI) CEO Sharon Mates on Q2 2018 Results - Earnings Call Transcript
Intra-Cellular Therapies, Inc. (ITCI) Q2 2018 Earnings Conference Call August 02, 2018 8:30 AM ET Executives Juan Sanchez – Vice President of Investor Relations Sharon Mates – Chairman and Chief Executive Officer Larry Hineline – Vice President and Chief Fina...
Source: SeekingAlpha
Date: August, 04 2018 09:42

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-09-1421.5021.7221.8321.23182,905
2017-08-0711.3810.9811.4410.95198,798
2017-08-0410.9611.3511.4710.83232,100
2017-08-0311.2410.9811.5510.87157,912
2017-08-0211.2411.2111.3510.68207,714

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-1340,40566,27260.9684Short
2018-12-1248,879104,30446.8621Short
2018-12-11295,635459,65864.3163Short
2018-12-1043,79579,97454.7615Short
2018-12-0786,583152,73556.6884Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on ITCI.


About Intra-Cellular Therapies Inc. (NASDAQ: ITCI)

Logo for Intra-Cellular Therapies Inc. (NASDAQ: ITCI)

Not available

 

 

 

Current Management

  • Sharon Mates / President, CEO
  • Lawrence Hineline / CFO, VP, Fin.
  • Sharon Mates / Chairman

Current Share Structure

  • Market Cap: $1,207,149,107 - 05/17/2018
  • Issue and Outstanding: 54,696,380 - 05/03/2018

 


Recent Filings from (NASDAQ: ITCI)

Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: August, 02 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: August, 02 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: June, 21 2018
Securities offered to employees under employee benefit plans
Filing Type: S-8Filing Source: edgar
Filing Date: June, 21 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 03 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 03 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: April, 27 2018
Additional proxy soliciting materials - definitive
Filing Type: DEFA14AFiling Source: edgar
Filing Date: April, 27 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 13 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 01 2018

 

 


Daily Technical Chart for (NASDAQ: ITCI)

Daily Technical Chart for (NASDAQ: ITCI)


Stay tuned for daily updates and more on (NASDAQ: ITCI)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: ITCI)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in ITCI is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of ITCI and does not buy, sell, or trade any shares of ITCI. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/